Paper40097577
The fibroinflammatory response in cancer.
Xiao Z and 1 other. Nat Rev Cancer, 2025. Cited by 50 papers, by iCite.
Cite this record
ConductScience Library. The fibroinflammatory response in cancer. Papers, record 40097577. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40097577
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Tumor Microenvironment | Major topic |
| Inflammation | Major topic |
| Fibroblasts | Major topic |
| Humans | |
| Animals | |
| Fibrosis |
Source PubMed
References302
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19931152 | Matrix crosslinking forces tumor progression by enhancing integrin signaling. | Cell | 2009 | https://conductscience.org/library/papers/19931152 | PubMed |
| 2 | 30130584 | Matrix modeling and remodeling: A biological interplay regulating tissue homeostasis and diseases. | Matrix Biol | 2019 | https://conductscience.org/library/papers/30130584 | PubMed |
| 3 | 28486109 | Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy. | Cancer Cell | 2017 | https://conductscience.org/library/papers/28486109 | PubMed |
| 4 | 29443960 | TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. | Nature | 2018 | https://conductscience.org/library/papers/29443960 | PubMed |
| 5 | 38039967 | The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer. | Immunity | 2023 | https://conductscience.org/library/papers/38039967 | PubMed |
| 6 | 31144616 | DDR2 controls breast tumor stiffness and metastasis by regulating integrin mediated mechanotransduction in CAFs. | Elife | 2019 | https://conductscience.org/library/papers/31144616 | PubMed |
| 7 | 19051218 | Close dependence of fibroblast proliferation on collagen scaffold matrix stiffness. | J Tissue Eng Regen Med | 2009 | https://conductscience.org/library/papers/19051218 | PubMed |
| 8 | 34106045 | Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment. | Elife | 2021 | https://conductscience.org/library/papers/34106045 | PubMed |
| 9 | 38168935 | Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy. | Nat Cancer | 2024 | https://conductscience.org/library/papers/38168935 | PubMed |
| 10 | 20627072 | Tumors as organs: complex tissues that interface with the entire organism. | Dev Cell | 2010 | https://conductscience.org/library/papers/20627072 | PubMed |
| 11 | 34644529 | Spatially confined sub-tumor microenvironments in pancreatic cancer. | Cell | 2021 | https://conductscience.org/library/papers/34644529 | PubMed |
| 12 | 26390428 | A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma. | Pancreas | 2016 | https://conductscience.org/library/papers/26390428 | PubMed |
| 13 | 28564607 | Specification and Diversification of Pericytes and Smooth Muscle Cells from Mesenchymoangioblasts. | Cell Rep | 2017 | https://conductscience.org/library/papers/28564607 | PubMed |
| 14 | 35365629 | Single-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1+ macrophages in colorectal cancer. | Nat Commun | 2022 | https://conductscience.org/library/papers/35365629 | PubMed |
| 15 | 28368410 | Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1. | Oncogene | 2017 | https://conductscience.org/library/papers/28368410 | PubMed |
| 16 | 25473038 | Wound repair and regeneration: mechanisms, signaling, and translation. | Sci Transl Med | 2014 | https://conductscience.org/library/papers/25473038 | PubMed |
| 17 | 23728338 | Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression. | Oncogene | 2014 | https://conductscience.org/library/papers/23728338 | PubMed |
| 18 | 34336660 | CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion. | Front Oncol | 2021 | https://conductscience.org/library/papers/34336660 | PubMed |
| 19 | 31394082 | Epidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young Adults. | Gastroenterology | 2020 | https://conductscience.org/library/papers/31394082 | PubMed |
| 20 | 36270275 | Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin. | Cancer Cell | 2022 | https://conductscience.org/library/papers/36270275 | PubMed |
Cited by45
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42966878 | Loss of Lepr in Fibroblasts Drives Tumor Development by Promoting Macrophage Infiltration. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42966878 | PubMed |
| 42902290 | ADAM12 in a stromal-checkpoint framework: integrating tumor microenvironment remodeling and therapy resistance in solid tumors. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42902290 | PubMed |
| 42859163 | Metabolic reprogramming in cancer-associated fibroblasts: orchestrating the tumor immune microenvironment and response to immune checkpoint blockade. | Exp Hematol Oncol | 2026 | https://conductscience.org/library/papers/42859163 | PubMed |
| 42850294 | [Contrast agent strategies in elective oncological imaging]. | Radiologie (Heidelb) | 2026 | https://conductscience.org/library/papers/42850294 | PubMed |
| 42787877 | Balancing immunosuppression and cancer survival in the treatment of immune checkpoint inhibitor-associated inflammatory arthritis. | EULAR Rheumatol Open | 2026 | https://conductscience.org/library/papers/42787877 | PubMed |
| 42784692 | Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer. | Science | 2026 | https://conductscience.org/library/papers/42784692 | PubMed |
| 42768179 | Understanding and targeting the tumour matrisome. | Nat Rev Clin Oncol | 2026 | https://conductscience.org/library/papers/42768179 | PubMed |
| 42706582 | Tumor-intrinsic NSUN2 orchestrates immunosuppression in lung adenocarcinoma via the m5C-HDAC8-CCL5 axis. | Exp Hematol Oncol | 2026 | https://conductscience.org/library/papers/42706582 | PubMed |
| 42694678 | Cancer-associated fibroblasts and immune remodeling in laryngeal squamous cell carcinoma: evidence and translational perspectives. | Front Immunol | 2026 | https://conductscience.org/library/papers/42694678 | PubMed |
| 42693091 | PPARα activation overcomes fibroinflammatory liver microenvironment-associated anti-PD-1 resistance in hepatocellular carcinoma by mediating GSDME-dependent pyroptosis. | Nat Commun | 2026 | https://conductscience.org/library/papers/42693091 | PubMed |
| 42688889 | Molecular insights of a Unani formulation in targeting fibrosis-associated diseases. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42688889 | PubMed |
| 42683260 | Exercise interventions remodel the aging microenvironment to improve prognosis in older patients with cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/42683260 | PubMed |
| 42622885 | RaFiST: a radiomics model for non-invasive stratification of tumor fibrosis and prognostic prediction in non-small cell lung cancer. | Eur Radiol | 2026 | https://conductscience.org/library/papers/42622885 | PubMed |
| 42457720 | Local, but not circulating, complement C3 shapes immune checkpoint blockade efficacy by controlling myeloid cell infiltration. | Nat Commun | 2026 | https://conductscience.org/library/papers/42457720 | PubMed |
| 42452969 | Reprogramming the Immunosuppressive Microenvironment in Triple-Negative Breast Cancer via FAP-Targeted Nanoprobes for Multimodal Imaging and Photothermal Therapy. | Adv Mater | 2026 | https://conductscience.org/library/papers/42452969 | PubMed |
| 42417161 | The extracellular matrix in cancer-associated fibrosis: molecular mechanisms and clinical relevance. | JCI Insight | 2026 | https://conductscience.org/library/papers/42417161 | PubMed |
| 42305546 | The trinity of T cell engagement: navigating the molecular and clinical landscape of CAR-T, TILs, and TCEs in the war against cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/42305546 | PubMed |
| 42292370 | Research progress on tumor extracellular matrix stiffness and immunosuppression. | Front Immunol | 2026 | https://conductscience.org/library/papers/42292370 | PubMed |
| 42278381 | Dihydrosanguinarine: A Review of Its Pharmacology, Structure-Activity Relationship, Toxicity, Pharmacokinetics, and Clinical Prospects. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42278381 | PubMed |
| 42219498 | Bidirectional crosstalk between cancer-associated fibroblasts and tumor immunity: shaping the microenvironment and response to immune checkpoint therapy. | Exp Hematol Oncol | 2026 | https://conductscience.org/library/papers/42219498 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40097577
GET https://conductscience.org/api/papers/v1/40097577/references?page=2